Liminal Biosciences Inc is a clinical stage biopharmaceutical company focusedon developing distinctive novel small molecule therapeutics forinflammatory, fibrotic, and metabolic diseases using our drug discoveryplatform and a data driven approach. The company has activebusiness operations in Canada and the United Kingdom.
Quote | Liminal Biosciences Inc (NASDAQ:LMNL)
Last: | $8.50 |
---|---|
Change Percent: | 0.24% |
Open: | $8.48 |
Close: | $8.50 |
High: | $8.5 |
Low: | $8.48 |
Volume: | 5,095 |
Last Trade Date Time: | 09/25/2023 03:00:00 am |
News | Liminal Biosciences Inc (NASDAQ:LMNL)
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Liminal BioSciences Inc. (LMNL) is expected to report for Q3 2023
Message Board Posts | Liminal Biosciences Inc (NASDAQ:LMNL)
Subject | By | Source | When |
---|---|---|---|
Liminal BioSciences Announces Arrangement Agreement with Structured Alpha LP | Awl416 | investorshub | 07/12/2023 11:33:35 AM |
$LMNL Price trading | pennygame$10 | investorshub | 07/09/2023 11:41:50 PM |
The now last up | rynlrt | investorshub | 07/09/2023 2:42:09 PM |
$LMNL Lets go go go go... Up up and away we go. | ZimZum | investorshub | 07/07/2023 10:43:18 PM |
MomentumIts now | $treet $inatra | investorshub | 07/04/2023 12:40:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Liminal Biosciences Inc Company Name:
LMNL Stock Symbol:
NASDAQ Market:
Liminal Biosciences Inc Website:
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Liminal BioSciences Inc. (LMNL) is expected to report for Q3 2023
LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP Canada NewsWire LAVAL, QC and CAMBRIDGE, England , Sept. 26, 2023 /CNW/ - Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company") is pleased to announce tha...